Cooper Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$287K Hold
248
– – 0.12% 43
2026
Q2
$297K Hold
248
– – 0.13% 37
2026
Q1
$228K Hold
248
– – 0.16% 32
2025
Q4
$267K Buy
+248
New +$237K 0.17% 35
2025
Q2
– Sell
-248
Closed -$205K – 39
2025
Q1
$205K Buy
+248
New +$206K 0.22% 30

Other funds holding LLY

Cooper Capital Advisors's LLY Position: Q3 2026 in Review

Cooper Capital Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 248 shares worth $287K. The position accounts for 0.12% of the portfolio, ranked #43.

Cooper Capital Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $297K in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cooper Capital Advisors held 248 shares of Eli Lilly worth $287K as of Q3 2026.
  • Cooper Capital Advisors left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.12% of Cooper Capital Advisors's portfolio in Q3 2026, its #43 holding.
  • Cooper Capital Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Cooper Capital Advisors's Eli Lilly position peaked at $297K in Q2 2026.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cooper Capital Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.